CAP survey responses

From: O'Donahue, Melanie . (ODonahue.Melanie@MAYO.EDU)
Date: Fri Jan 04 2002 - 13:50:32 EST


Here is a synopsis of the responses to the CAP survey question:

Question: We have difficulties setting the gates appropriately due
to the quite altered scatter pattern of the preserved survey specimens. We
also have issues with low white cell counts. Does anyone else have these or
other problems? Do you have any suggestions for processing or analyzing that
we could try?

1:	The surveys have had very low white counts--I manufacture them.
You might want to wash the cells in RPMI and concentrate the cells.  This
will work if you are not doing absolute counts.

2.	We routinely use three color analysis, however when we have a sample

that has red cells resistant to lysing, or an old shipped sample, we
add CD45 APC.

3.	I have been evaluating CAP Lymphocyte panel for several years and
have not
experienced any light scatter problems nor any gating problems.  The only
difference is that I report out %Total and have to calculate differently to
report out %gated, however use the same analysis templates that we use for
our patient sample (PB, BM, PBPC, UCB).  I run CD Chex simultaneously as a
control.
We use a stain-lyse-wash technique and usually perform a cell count on the
samples, adjusting to 1e7 per mL using 100uL per test.	If counts are low, I
use 100uL of sample and resuspend in 200-250uL for acquisition; acquiring
20,000 total events.

4.	We live on the West coast of Canada and received our samples 7 days
after
the date that most of the participants received and ran their samples. The
viability of our samples was not great and the scatter plots weren't either.
We normally use FS vs. logSS and found the lymph population to have higher
SS
than the grans but with the usual FS. We did our best but had it been a
clinical sample we would have been interpreting with much caution. We used
isotypic controls whenever possible on both cases and CD45 vs. SS gating on
FL3-04 (where scatterplot was difficult to interpret, viability was poor and
we thought it might be a high grade lymphoma/leukemia).

5.	We failed once many many years ago-someone did not transcribe the
appropriate data from the graphics to the cap form correctly. I would check
this first before pulling out the facscomp report from the day you ran them
or looking at the raw data again...

6.	The immunophenotyping cells are cell lines and are generally large.
To
date in all the proficiencies I see, there is only one cell line present so
it is not too hard to adjust scatter settings to find them.  It seems we
have to accept that.

I also feel that the survey for T4 etc are problematic with low counts.
The low counts can be frustrating.

7.	You're right, it shouldn't matter about instrument or panel and
instrument
and fluorochromes are taken into account when the samples are evaluated by
CAP. If %positives are outside range,
you might try looking at a dot-plot of CD3 vs. SSC (routine samples and CAP)
to determine if you have any 'escapees'.  This can happen, depending upon
anticoagulant, fluorochrome combination and/or centrifugation speed.  I
minimized this problem by using CD45 FITC and CD3 PerCP and washing at 150g
for 5min.


Thank you all for your responses! We are doing much of what was suggested,
but will try a few new things with the next survey, such as concentrating
the specimen and viewing CD3 vs. SSC. I will also fax the graphs after the
results come back for the next survey to anyone who would like to discuss it
further.

Thanks for your valuable time and input,


Melanie O'Donahue, MT, ASCP
Mayo Clinic Scottsdale
Laboratory Medicine
Flow Cytometry Lead Technologist
Odonahue.Melanie@mayo.edu
480-301-8028



This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:59:19 EST